Authors: A.J. Thote and R.B. Gupta
Affilation: Auburn University, United States
Pages: 116 - 119
Keywords: sustained, controlled drug release, dexamethasone phosphate, PLGA, SAS-EM, s/o/o/o
The problem of initial burst release, in sustained drug delivery devices was resolved by reducing the active pharmaceutical ingredient particle size by using Supercritical Antisolvent technique with Enhanced Mass-transfer (SAS-EM)., Encapsulation was performed using a nonaqueous s/o/o/o technique giving high encapsulation efficiencies for hydrophilic drugs. Using SAS-EM, dexamethasone phosphate nanoparticles were obtained in the range of 150-200 nano-meter. Upon encapsulation in PLGA, composite microspheres of ~70 micro-meter were obtained with about 90% drug encapsulated. The in-vitro drug release study of these microparticle/nanoparticle composites showed sustained drug release over 700 hours with negligible burst release.